Home
/
AVENUE THERAPEUTICS, INC.
/
Financials
/
Quarterly
AVENUE THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AVENUE THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 13, 2025
Q2
2025
Jun 30, 2025
$1.40M
Aug 14, 2025
Q3
2025
Sep 30, 2024
$0
Nov 13, 2025
Q2
2025
Jun 30, 2024
$0
Aug 14, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($683.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
$335.0K
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.85M)
May 15, 2025
Q3
2025
Sep 30, 2024
($3.08M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($2.69M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($4.34M)
May 15, 2025
Q3
2024
Sep 30, 2023
$526.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
($4.01M)
Aug 9, 2024
Q3
2022
Sep 30, 2022
($662.0K)
Nov 10, 2022
Q2
2022
Jun 30, 2022
($604.0K)
Aug 15, 2022
Q1
2022
Mar 31, 2022
($2.86M)
May 16, 2022
Q3
2022
Sep 30, 2021
($871.0K)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($949.0K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($998.0K)
May 16, 2022
Q3
2021
Sep 30, 2020
($1.03M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.89M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($1.24M)
May 17, 2021
Q3
2020
Sep 30, 2019
($2.24M)
Nov 4, 2020
Q2
2020
Jun 30, 2019
($6.98M)
Aug 14, 2020
Q1
2020
Mar 31, 2019
($11.27M)
May 11, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($724.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
$297.0K
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.91M)
May 15, 2025
Q3
2025
Sep 30, 2024
($3.16M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($2.82M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($3.71M)
May 15, 2025
Q3
2024
Sep 30, 2023
($2.07M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($3.92M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($6.43M)
May 15, 2024
Q3
2023
Sep 30, 2022
($663.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($605.0K)
Aug 11, 2023
Q2
2023
Jun 3, 2022
($3.47M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($2.86M)
May 12, 2023
Q3
2022
Sep 30, 2021
($872.0K)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($951.0K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.00M)
May 16, 2022
Q3
2021
Sep 30, 2020
($1.04M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.90M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($1.27M)
May 17, 2021
Q3
2020
Sep 30, 2019
($2.32M)
Nov 4, 2020